| 1 |
Martínez-iglesias O, Naidoo V, Carrera I, Corzo L, Cacabelos R. Natural Bioactive Products as Epigenetic Modulators for Treating Neurodegenerative Disorders. Pharmaceuticals 2023;16:216. [DOI: 10.3390/ph16020216] [Reference Citation Analysis]
|
| 2 |
Martínez-Iglesias O, Naidoo V, Corzo L, Pego R, Seoane S, Rodríguez S, Alcaraz M, Muñiz A, Cacabelos N, Cacabelos R. DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders. Genes (Basel) 2023;14. [PMID: 36833292 DOI: 10.3390/genes14020365] [Reference Citation Analysis]
|
| 3 |
Tirozzi A, Quiccione MS, Cerletti C, Donati MB, de Gaetano G, Iacoviello L, Gialluisi A. A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer's and Parkinson's Disease. Cells 2023;12. [PMID: 36672180 DOI: 10.3390/cells12020245] [Reference Citation Analysis]
|
| 4 |
Rasmi Y, Shokati A, Hassan A, Aziz SG, Bastani S, Jalali L, Moradi F, Alipour S. The role of DNA methylation in progression of neurological disorders and neurodegenerative diseases as well as the prospect of using DNA methylation inhibitors as therapeutic agents for such disorders. IBRO Neurosci Rep 2023;14:28-37. [PMID: 36590248 DOI: 10.1016/j.ibneur.2022.12.002] [Reference Citation Analysis]
|
| 5 |
Liu WW, Sun Y. Epigenetics in glaucoma: a link between DNA methylation and neurodegeneration. J Clin Invest 2022;132. [PMID: 36317630 DOI: 10.1172/JCI163670] [Reference Citation Analysis]
|
| 6 |
León I, Herrero Roldán S, Rodrigo MJ, López Rodríguez M, Fisher J, Mitchell C, Lage-castellanos A. The shared mother-child epigenetic signature of neglect is related to maternal adverse events. Front Physiol 2022;13:966740. [DOI: 10.3389/fphys.2022.966740] [Reference Citation Analysis]
|
| 7 |
Li YZ, Wu ZY, Zhu BQ, Wang YX, Kan YQ, Zeng HC. The BDNF-TrkB-CREB Signalling Pathway Is Involved in Bisphenol S-Induced Neurotoxicity in Male Mice by Regulating Methylation. Toxics 2022;10:413. [PMID: 35893846 DOI: 10.3390/toxics10080413] [Reference Citation Analysis]
|
| 8 |
Coppedè F, Cereda C, Lintas C, Stoccoro A. Editorial: Epigenetics of Neurodevelopmental, Neuromuscular and Neurodegenerative Disorders. Front Mol Neurosci 2022;15:948827. [PMID: 35754706 DOI: 10.3389/fnmol.2022.948827] [Reference Citation Analysis]
|
| 9 |
Bandopadhyay R, Mishra N, Rana R, Kaur G, Ghoneim MM, Alshehri S, Mustafa G, Ahmad J, Alhakamy NA, Mishra A. Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence. Front Pharmacol 2022;13:805388. [DOI: 10.3389/fphar.2022.805388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Martínez-Iglesias O, Naidoo V, Carrera I, Cacabelos R. Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease. Int J Mol Sci 2022;23:2446. [PMID: 35269588 DOI: 10.3390/ijms23052446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
